News and History
Life Science News and History
LifeScienceHistory.com (LSH), “Where history is made daily” is a comprehensive compendium of life science. Simply put, we dig history and we mine data daily.
LSH grew from frustration with the difficulty in easily finding historical information about life science, and the industry in general. Most seemed to be the same old duped lists of facts, rarely with images, nor links for more information, and almost never sourced.
LSH news and history are presented in a concise, easily readable format with images, all sourced, link-checked and content brought up-to-date where possible, because history is made daily. This means that we bring you the history making events from last week, as well as from last year and beyond. Search by state, province or nation.
-
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion USD
Read More: Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion USDOn May 7, 2026, Angelini Pharma and Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and
-
Thousands of previously unknown proteins discovered
Read More: Thousands of previously unknown proteins discoveredOn May 6, 2026, a group of international researchers announced they had discovered 1,700 new proteins. The research
-
Roche agrees to acquire US-based PathAI for $1 Billion
Read More: Roche agrees to acquire US-based PathAI for $1 BillionOn May 6, 2026, Swiss pharmaceutical giant Roche announced it had agreed to acquire U.S.-based digital pathology and
-
USC launches transformational AI initiative with $200 million gift
Read More: USC launches transformational AI initiative with $200 million giftOn May 5, 2026, the University of Southern California (USC) announced a transformational initiative that will leverage AI
-
Study Reports unprecedented view of the immune system’s killer cells
Read More: Study Reports unprecedented view of the immune system’s killer cellsOn May 4, 2026, a study conducted by the University of Geneva and the Lausanne University Hospital (CHUV)
-
UCB to acquire Candid Therapeutics for more Than $2 Bllion, building upon its existing immunology pipeline
Read More: UCB to acquire Candid Therapeutics for more Than $2 Bllion, building upon its existing immunology pipelineOn May 3, 2026, UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it
-
Canada approves second generic semaglutide, the first G7 country to do so
Read More: Canada approves second generic semaglutide, the first G7 country to do soOn May 1, 2026, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other
-
Researchers create groundbreaking first-draft map of genetic interactions within human cells
Read More: Researchers create groundbreaking first-draft map of genetic interactions within human cellsOn Apr. 30, 2026, researchers at the University of Bonn and University Hospital Bonn have created a groundbreaking
-
Colossal Biosciences Is Working to Bring Back the Bluebuck, an Antelope Hunted to Extinction in 1800
Read More: Colossal Biosciences Is Working to Bring Back the Bluebuck, an Antelope Hunted to Extinction in 1800On Apr. 30, 2026, Colossal Biosciences, the world’s de-extinction company, announced that it is working to de-extinct the
-
Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biolog
Read More: Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated BiologOn Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global
-
Scientists Create First-Ever ‘Smell Map’
Read More: Scientists Create First-Ever ‘Smell Map’On Apr. 28, 2026, scientists Sandeep (Robert) Datta, professor of neurobiology in the Blavatnik Institute at Harvard Medical
-
Mayo Clinic study points to changes decades before Alzheimer’s symptoms
Read More: Mayo Clinic study points to changes decades before Alzheimer’s symptomsOn Apr. 28, 2026, new research from the Mayo Clinic show subtle biological changes linked to Alzheimer’s disease
-
U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder
Read More: U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I DisorderOn Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough
-
FDA Announces Major Steps to Implement Real-Time Clinical Trials
Read More: FDA Announces Major Steps to Implement Real-Time Clinical Trials -
Purdue Pharma sentenced in connection with its 2020 Plea Agreement with U.S. Department of Justice
Read More: Purdue Pharma sentenced in connection with its 2020 Plea Agreement with U.S. Department of Justice -
Sun Pharma, India’s Largest drug Firm to Buy U.S., to Acquire Organon for $11.75 Billion
Read More: Sun Pharma, India’s Largest drug Firm to Buy U.S., to Acquire Organon for $11.75 BillionOn Apr. 27, 2026, Sun Pharmaceutical Industries and Organon announced they have entered into an agreement under which
-
Princeton scientists make 3D bio-electronic hybrid system using brain cells
Read More: Princeton scientists make 3D bio-electronic hybrid system using brain cellsOn Apr. 24, 2026, researchers at Princeton University announce they have developed a 3-dimensional device that merges living
-
UK Trials Show Paxlovid speeds recovery, but doesn’t reduce hospitalization in vaccinated patients
Read More: UK Trials Show Paxlovid speeds recovery, but doesn’t reduce hospitalization in vaccinated patientsOn Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)
-
Girl’s sight restored after ‘life-changing’ gene therapy
Read More: Girl’s sight restored after ‘life-changing’ gene therapyOn Apr. 23, 2026, a research team at the University College London (UCL) and Great Ormond Street Hospital
-
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
Read More: FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing LossOn Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual
